Mark Bachleda

Chief Executive Officer (CEO), Eyconis, Inc.

Role
Director, Board of Directors at Lyell Immunopharma
Location
Seattle, WA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Mark Bachleda

A biopharmaceutical executive with broad experiences in general management and commercialization in ophthalmology, hematology, oncology, cardiovascular, neuroscience, and other therapeutic areas in US & International markets for public & private, large & small biopharma companies.

Experience

  1. Director, Board of Directors

    Lyell Immunopharma

    Jun 2025 — Present · South San Francisco, CA, US

    Member of the Nominating and Corporate Governance Committee

Education

  • University of California, Berkeley, Haas School of Business

    MBA, Business

    2005 — 2007

  • Moraine Valley Community College

    Associate of Science (A.S.), Biological Sciences

    1993 — 1995

  • London Business School

    Summer Program, Globalization, Markets and the Changing Economic Landscape

    2006 — 2006

  • University of Illinois Chicago

    Pharm.D., College of Pharmacy

    1995 — 1999

  • Columbia University

    MBA, Business

    2005 — 2007

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mark Bachleda — Director, Board of Directors at Lyell Immunopharma in Seattle, WA, US | Unifers